Adnan M Nagrial Selected Research

Adnan M Nagrial Research Topics

8	Adenocarcinoma 01/2020 - 04/2013
7	Neoplasms (Cancer) 11/2018 - 11/2012
6	Pancreatic Neoplasms (Pancreatic Cancer) 01/2017 - 11/2012
2	Melanoma (Melanoma, Malignant) 04/2015 - 01/2015
1	Retinoblastoma (Glioblastoma, Retinal) 12/2018
1	Disease Progression 01/2017
1	Neoplasm Metastasis (Metastasis) 01/2017
1	Ischemic Stroke 10/2015
1	Hypertension (High Blood Pressure) 10/2015
1	Genomic Instability 02/2015

3	Gemcitabine FDA Link 01/2017 - 06/2014
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 04/2013
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 04/2015 - 01/2015
1	Retinoblastoma ProteinIBA 12/2018
1	Cyclin-Dependent Kinase 4IBA 12/2018
1	rho-Associated KinasesIBA 01/2017
1	fasudil (AT 877)IBA 01/2017
1	CDC2 Protein Kinase (Protein p34cdc2)IBA 01/2017
1	Pharmaceutical PreparationsIBA 01/2017
1	Albumin-Bound Paclitaxel FDA Link 01/2017
1	Immune Checkpoint InhibitorsIBA 01/2017
1	ChromatinIBA 03/2016
1	PhosphotyrosineIBA 01/2016
1	Biomarkers (Surrogate Marker)IBA 01/2016
1	Protein Kinases (Protein Kinase)IBA 10/2015
1	Vasodilator Agents (Vasodilators)IBA 10/2015
1	DNA (Deoxyribonucleic Acid)IBA 02/2015
1	Phosphotransferases (Kinase)IBA 01/2015
1	VemurafenibIBA 01/2015
1	dabrafenibIBA 01/2015
1	Fluorouracil (Carac)FDA LinkGeneric 06/2014
1	folfirinoxIBA 06/2014
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 06/2014
1	130-nm albumin-bound paclitaxelIBA 06/2014
1	Irinotecan (Camptosar)FDA LinkGeneric 06/2014
1	Leucovorin (Folinic Acid)FDA Link 06/2014